Renal Function Improvement by Telbivudine in Liver Transplant Recipients with Chronic Kidney Disease

Figure 7

The eGFR for the patients in LdT arm and switched back to LAM. During post hoc following-up, 9 patients had polyneuropathy and were switched back to LAM. While LdT was switched back to LAM, eGFR was kept in improved renal function in 5 (55.6%) patients and returned to original levels in 4 (44.4%) patients.